PubMed ID:
31101018
Public Release Type:
Journal
Publication Year: 2019
Affiliation: Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA. Jochen.Raimann@rriny.com.; Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA.; Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA.; Cleveland Clinic Foundation, Cleveland, OH, USA.; Cleveland Clinic Foundation, Cleveland, OH, USA.; Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA.; Renal Research Institute, 315 East 62nd Street, 4th Floor, New York, NY, 10065, USA.; University of Massachusetts Lowell, Lowell, MA, USA.
DOI:
https://doi.org/10.1186/s12882-019-1311-4
Authors:
Raimann Jochen G, Abbas Samer R, Liu Li, Larive Brett, Beck Gerald, Kotanko Peter, Levin Nathan W, Handelman Garry
Request IDs:
20628
,
21520
Studies:
Frequent Hemodialysis Network Daily Trial
Reports on vitamin C in HD patients have shown effects of vitamin C deficiency in association with scurvy symptoms. Dialyzability of water soluble vitamins is high, and substantial losses in those who are dialyzed more frequently were hypothesized. The randomized FHN Daily Trial compared the effects of in-center HD six versus three times per week. We studied baseline correlations between vitamin C and potentially associated parameters, and the effect of more frequent HD on circulating vitamin C concentrations.